The Genecept Assay: An Innovation for Neuropsychiatry
The Genecept Assay is a comprehensive, simple to use tool for understanding genetic and biological markers that best inform responses to different psychiatric treatments.
The Assay is Genomind’s core product. It consists of a proprietary panel of 10 biomarkers, an analytic report, and consultation with a psychopharmacologist.
The Assay’s purpose is to help clinicians more quickly find appropriate, effective treatment based on individual patients’ physiological and genetic profile. It can be used for patients with a range of difficult to treat psychiatric conditions including depression, bipolar disorder, schizophrenia, anxiety disorders, OCD and ADHD.
How does it work?
The Genecept Assay is simple to use.
- Order a test kit.
- Patient provides 1ml of saliva – about a small spoonful – into a tube and the clinician mails the sample in a postage-paid shipping package to our lab.
- Genomind’s lab will analyze the DNA in 3-5 business upon receipt of the saliva sample.
- Genomind will send the patient’s genetic test results in a report, with clinical interpretations, directly to the clinician.
- A psychopharmacologist will be readily available to provide a consult on the results. The clinician is able to consider this additional information when they make a treatment decision for their patient.